Navigation Links
Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Date:5/28/2009

and Patient Instructions for Use.

About Trabectedin

Trabectedin is a novel cytotoxic antitumor agent that was originally derived from the Caribbean tunicate, Ecteinascidia turbinate ("sea squirt"). The compound is now produced synthetically. Trabectedin binds to the minor groove of DNA, interfering with cell division and genetic transcription processes and DNA repair machinery. Trabectedin is currently in Phase 3 development in ovarian cancer and to expand its uses in sarcoma.

According to the licensing agreement, PharmaMar SAU has rights to market the compound in Europe and Japan, while Centocor Ortho Biotech Products, L.P. has marketing rights for the product in the rest of the world.

About Centocor Ortho Biotech Products, L.P.

Centocor Ortho Biotech redefines the standard of care in immunology, nephrology, and oncology. The company was formed when Centocor, Inc. and Ortho Biotech Products, L.P. were consolidated in late 2008, and was renamed Centocor Ortho Biotech. Built upon a pioneering history, Centocor Ortho Biotech harnesses innovations in large-molecule and small-molecule research to create important new therapeutic options. Beyond its innovative medicines, Centocor Ortho Biotech is at the forefront of developing education and public policy initiatives to ensure patients and their families, caregivers, advocates, and healthcare professionals have access to the latest treatment information, support services, and quality care.

Note: This release corresponds to ASCO abstracts 5526, 5550, 5551, 8591 and 9625


'/>"/>
SOURCE Centocor Ortho Biotech Products, L.P.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
2. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
3. Centocor/Janssen-Cilags Ustekinumab Will Become the Gold Standard for Psoriasis By 2011
4. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
5. Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product
6. GeneNews provides Centocor access to its osteoarthritis program
7. Baseline Research Indicates High Interest in Centocor-Ortho Biotechs SIMPONI(R)
8. Ortho Biotech Supports FDA Advisory Committees Recommendations on Use of ESAs in Chronic Renal Failure Patients
9. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
10. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
11. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Blood America, Inc. (OTC Bulletin Board: CBAI), the ... http://www.cordblood-america.com ) focused on bringing the life ... policy, to families nationwide and internationally, said today ... total of $1.4 million so far in the ... for the year now tops $10 million. ,, ...
(Date:12/16/2009)... fiscal 2009; on track for positive cash flow ... - Microbix Biosystems Inc. (MBX:TSX) a biotechnology company ... financial results for fourth quarter and full-year 2009. ... Microbix reported revenues of $6.08 million, a 22% ... fourth-quarter 2009, the Company saw revenues increase by ...
(Date:12/16/2009)... has what scientists have been asking for! Zap-CHO is a ... and productivity of CHO cells. Developed for scientists seeking maximum ... defined and consistent recombinant CHO supplement. , ... ... Scientists working with CHO cells can now access an informational ...
(Date:12/16/2009)... Annual Technical Conference & Exhibition on March 22-25, 2010 at the ... separation society and reach out to even more experts in the ... Technical Conference will be co-located with the 2010 AIChE Spring National ... ... 2009 -- The American Filtration and Separations Society will hold its ...
Breaking Biology Technology:Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4
... and KENILWORTH, N.J., Nov. 6 Centocor,Inc., ... today that an estimated one million patients ... leading anti-tumor necrosis,factor (TNF)-alpha therapy worldwide. In ... patients worldwide than all other anti-TNF-alpha agents,combined. ...
... and VALAIS, Switzerland, Nov. 5 ,Lantibio, Inc. and TRB ... a subsidiary of Alcon, Inc. (NYSE: ACL ) ... Eye Syndrome product. The,product consists of a TRB patented ... the US under an IND by a,subsidiary of Lantibio. ...
... to 3Q06 to $43.5 Million in 3Q07 -,- 3Q07 Net Income Increased 58% ... ... - Company Provides Financial Outlook for 2007 and ... AOB ), a leading manufacturer and distributor of,plant-based pharmaceutical and nutraceutical products, today ...
Other Biology Technology:REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 2REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 3REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 4REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 5REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 6REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 7REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 8REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 9REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 10REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 11REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 12Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 3Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 4American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 2American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 3American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 4American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 5American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 6American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 7American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 8
(Date:12/15/2009)... San Diego, California, has been awarded an accreditation ... on results of a recent onsite inspection. ... this national recognition and congratulated for the "excellence ... GenWay Clinical Laboratory is one of nearly 7,000 ... Program, begun in the early 1960s, is recognized ...
(Date:12/15/2009)... is available in German ., Despite ... across the globe, cultures vary as to how space ... not use egocentric terms such as ,left, right, front, ... notions like ,north, south, east, west, at all times ... bowl" or "There is an snake by your Northern ...
(Date:12/15/2009)... In the near future, consumers can look forward ... such as laptops, PDAs and mobile phones. This ... energy harvesting technologies which are critical elements for ... devices and systems. , Analog IC design is ... energy harvesting. To pre-position the nation in advanced ...
Breaking Biology News(10 mins):More than a jump to the left 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3Doctors Join Patients to Protest at Health Care Freedom Tea Parties July 17 3B Thousands Join in Nationwide Event 51910 1Dow AgroSciences NemGenix Establish New Collaboration in Plant Biotechnology 13065 1Dow AgroSciences NemGenix Establish New Collaboration in Plant Biotechnology 13065 2Branded Surgery Is Not Always the 26quot 3BQuick Fix 26quot 3B it is Advertised To Be 51902 1Branded Surgery Is Not Always the 26quot 3BQuick Fix 26quot 3B it is Advertised To Be 51902 2Branded Surgery Is Not Always the 26quot 3BQuick Fix 26quot 3B it is Advertised To Be 51902 3
... found that fresh water systems from across the northeastern United ... and the White Mountains of New Hampshire are becoming saltier ... Not only are there more roads, but the amount of ... fresh water systems reports Sujay Kaushal and colleagues in ...
... mild to moderate depression, say researchers in this week's ... which shows how human health and wellbeing are dependent ... study was carried out in Honduras and involved 30 ... assigned to the experimental group and half to the ...
... a wound in certain plants like roses and grapevines develop ... common soil bacterium that is able to "smell" the wound ... Steve Winans says that the pathogen Agrobacterium tumefaciens ... infection, which can slip into the plant's cells and their ...
Other Biology News:Fresh water affected by salt from deicing roads 2Swimming with dolphins can alleviate depression 2Plant wounds trigger bacteria 2